Related Experiment Videos
Summary
Lithium (Li+) can impair kidney function, frequently causing urinary concentration issues in 50% of patients, even without overt symptoms. These subtle effects highlight the need for careful monitoring during lithium therapy for manic-depressive illness.
Area of Science:
- Nephrology
- Endocrinology
- Pharmacology
Context:
- Lithium therapy is common for manic-depressive illness.
- Water balance disturbances are potential side effects.
- Previous studies have shown varied results on lithium's impact on water metabolism.
Purpose:
- To investigate the interaction between lithium (Li+) and water balance in patients with manic-depressive illness.
- To identify subclinical urinary concentration abnormalities induced by lithium.
- To explore the diurnal variations in renal lithium clearance.
Summary:
- Lithium induced nephrogenic diabetes insipidus in one of nine patients.
- Four patients showed impaired urinary concentration, responsive to ADH (antidiuretic hormone).
- Fifty percent of patients experienced subclinical urinary concentration defects, detectable only through biological tests, with both nephrogenic and central origins.
- Renal lithium clearance decreased after dehydration and increased after water loading, with a notable circadian rhythm.
Impact:
- Lithium frequently causes subclinical urinary concentration defects, necessitating biological monitoring.
- The findings suggest a dual origin (nephrogenic and central) for lithium-induced water metabolism disturbances.
- A novel methodology revealed a circadian rhythm in renal lithium clearance, potentially impacting lithium therapy practices.